Dogecoin Cash, Inc. Reports 13% Revenue Decline Amid Increased Competition

Dogecoin Cash, Inc. reported a revenue decline of 13% for the three months ended June 30, 2026, totaling $166.5 million, compared to $192.5 million in the same period of 2025. For the first half of 2026, revenue decreased by 5% to $359.4 million from $376.9 million in the prior year. The decrease in revenue is attributed to heightened competition in the cannabis telemedicine sector, which has led to compressed demand growth. Despite the revenue drop, the cost of revenues as a percentage of sales decreased by 13% in the second quarter and 7% in the first half, indicating improved cost management.

Total operating expenses for the second quarter of 2026 decreased by 29% to $217,515, down from $304,892 in Q2 2025. This reduction was primarily driven by a 42% decrease in general and administrative expenses, an 11% decrease in wages and salaries, and a 6% reduction in professional fees. For the first half of 2026, total operating expenses decreased by 4% to $500,896 compared to $523,473 in the same period of 2025. The net loss from continuing operations for the second quarter was $270,157, a slight improvement from a loss of $285,030 in Q2 2025.

The company’s cash position has also seen a significant decline, with cash on hand dropping to $10,971 as of June 30, 2026, from $29,553 at the end of 2025. Cash used in operating activities was $22,132 for the first half of 2026. The company reported an accumulated deficit of $84,714,880, raising concerns about its ability to continue as a going concern. Management indicated that raising capital through equity offerings or convertible debt may be necessary to support ongoing operations and growth strategies.

Operationally, Dogecoin Cash, Inc. continues to focus on its telehealth services through its subsidiary PrestoCorp, which provides medical cannabis referrals. The company has not reported any significant changes in customer counts or user statistics in this filing. However, it has indicated that the competitive landscape in the cannabis telemedicine industry remains challenging, impacting user engagement and market share. The company has also noted that it will rely on direct management oversight and external professionals to mitigate weaknesses in its internal controls due to a limited accounting staff.

Looking ahead, Dogecoin Cash, Inc. acknowledges the need for strategic capital raising to support its business plan. The management remains optimistic about future growth opportunities but recognizes the challenges posed by market conditions and competition. The company plans to continue monitoring its digital asset holdings and may explore further acquisitions to enhance its market position.